Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase CAMP-activated catalytic subunit beta divergent transcript (PRKACB-DT)
- Target
- PRKACB-DT
- Molecular classification
- Long non-coding RNA, Antisense transcript, Non-coding RNA
01
Overview
PRKACB-DT represents divergent, typically non-coding, transcripts from the PRKACB gene locus. These include tissue- and allele-specific long non-coding RNAs that appear to regulate the imprinting and expression of the protein-coding PRKACB gene, which is involved in cAMP-dependent protein kinase A signaling. While PRKACB is a well-characterized enzyme implicated in many pathological processes (notably cancer, heart defects, and neurodegeneration), PRKACB-DT has not been demonstrated as a direct therapeutic target and is best considered a regulatory RNA[1][4].
- Other names
- PRKACB antisense lncRNAlncPRKACBPRKACB long non-coding RNAPRKACB isoform divergent transcript
02
Mechanism of action
No drugs known; possible regulatory role as an antisense RNA modulating PRKACB expression
03
Biological functions
Potential regulation of PRKACB expression via genomic imprinting and allele-specific silencingMay influence tissue-specific transcription or epigenetic gene regulation
04
Disease associations
Not directly implicated; dysregulation of PRKACB sense/antisense balance may be relevant in developmental abnormalities and imprinting disorders
Beyond the preview
Go deeper on Protein kinase CAMP-activated catalytic subunit beta divergent transcript (PRKACB-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protein kinase CAMP-activated catalytic subunit beta divergent transcript (PRKACB-DT).